JPS6416A - Remedy for arthritis - Google Patents
Remedy for arthritisInfo
- Publication number
- JPS6416A JPS6416A JP62326294A JP32629487A JPS6416A JP S6416 A JPS6416 A JP S6416A JP 62326294 A JP62326294 A JP 62326294A JP 32629487 A JP32629487 A JP 32629487A JP S6416 A JPS6416 A JP S6416A
- Authority
- JP
- Japan
- Prior art keywords
- magnesium
- water
- remedy
- salt
- soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010003246 arthritis Diseases 0.000 title abstract 3
- 159000000003 magnesium salts Chemical class 0.000 abstract 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 abstract 2
- -1 inorganic acid salt Chemical class 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 208000008167 Magnesium Deficiency Diseases 0.000 abstract 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical group [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 abstract 1
- 229940043256 calcium pyrophosphate Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 abstract 1
- 229910001629 magnesium chloride Inorganic materials 0.000 abstract 1
- 235000004764 magnesium deficiency Nutrition 0.000 abstract 1
- 239000001755 magnesium gluconate Substances 0.000 abstract 1
- 229960003035 magnesium gluconate Drugs 0.000 abstract 1
- 235000015778 magnesium gluconate Nutrition 0.000 abstract 1
- 229910001425 magnesium ion Inorganic materials 0.000 abstract 1
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 abstract 1
- 235000015229 magnesium lactate Nutrition 0.000 abstract 1
- 229960004658 magnesium lactate Drugs 0.000 abstract 1
- 239000000626 magnesium lactate Substances 0.000 abstract 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 abstract 1
- 235000019341 magnesium sulphate Nutrition 0.000 abstract 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- 239000012188 paraffin wax Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PURPOSE: To obtain a remedy exhibiting anti-inflammatory action and effective to arthritis, etc., by using a water-soluble magnesium salt as a main component.
CONSTITUTION: The objective remedy contains a water-soluble magnesium salt, e.g. inorganic acid salt such as magnesium chloride or magnesium sulfate or organic acid salt such as magnesium gluconate or magnesium lactate. A slowly releasing agent having controllable releasing rate of magnesium ion independent to pH can be produced by coating a water-soluble magnesium salt with a pH-independent substance (e.g. hydrocarbon such as paraffin or hardened oil such as hydrogenated vegetable oil). The preparation is useful for the remedy of magnesium deficiency such as arthritis caused by the deposition of calcium pyrophosphate. It is administered at a rate of 0.5W10g, preferably 1W4g of the water-soluble magnesium salt daily in one or two divided doses.
COPYRIGHT: (C)1989,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62326294A JPS6416A (en) | 1986-12-23 | 1987-12-22 | Remedy for arthritis |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30671986 | 1986-12-23 | ||
| JP61-306719 | 1986-12-23 | ||
| JP62326294A JPS6416A (en) | 1986-12-23 | 1987-12-22 | Remedy for arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0116A JPH0116A (en) | 1989-01-05 |
| JPS6416A true JPS6416A (en) | 1989-01-05 |
Family
ID=26564841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62326294A Pending JPS6416A (en) | 1986-12-23 | 1987-12-22 | Remedy for arthritis |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6416A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4601449A (en) * | 1983-10-19 | 1986-07-22 | Westinghouse Electric Corp. | Electric pipe snubber |
| JPS6460329A (en) * | 1987-08-28 | 1989-03-07 | Japan Tobacco Inc | Production of coffee extract |
| JPH02180997A (en) * | 1988-10-14 | 1990-07-13 | Skw Trostberg Ag | Method for removing terpene from essential oil |
| US5244875A (en) * | 1991-05-06 | 1993-09-14 | Hauser Chemical Research, Inc. | Electroplating of superconductor elements |
| WO1995031991A3 (en) * | 1994-05-25 | 1996-02-15 | Giampiero Valletta | Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| JP2003534373A (en) * | 2000-06-02 | 2003-11-18 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Composition for treating and / or preventing osteoporosis and / or inflammatory joint disease |
| DE112006003954T5 (en) | 2006-07-18 | 2009-05-07 | Mitsubishi Electric Corp. | Device with a numerical control |
| JP2014501722A (en) * | 2010-11-18 | 2014-01-23 | アドビセンヌ | Pharmaceutical compositions comprising Krebs cycle precursor salts, in particular citrate, and their use as medicaments |
| EP4389120A1 (en) * | 2022-12-20 | 2024-06-26 | Inflacod Sp. z o.o. | An anti-inflammatory pharmaceutical composition |
-
1987
- 1987-12-22 JP JP62326294A patent/JPS6416A/en active Pending
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4601449A (en) * | 1983-10-19 | 1986-07-22 | Westinghouse Electric Corp. | Electric pipe snubber |
| JPS6460329A (en) * | 1987-08-28 | 1989-03-07 | Japan Tobacco Inc | Production of coffee extract |
| JPH02180997A (en) * | 1988-10-14 | 1990-07-13 | Skw Trostberg Ag | Method for removing terpene from essential oil |
| US5244875A (en) * | 1991-05-06 | 1993-09-14 | Hauser Chemical Research, Inc. | Electroplating of superconductor elements |
| WO1995031991A3 (en) * | 1994-05-25 | 1996-02-15 | Giampiero Valletta | Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| US6248368B1 (en) * | 1994-05-25 | 2001-06-19 | Giampiero Valletta | Use of magnesium based products for the treatment or prophylaxis of autoimmune diseases |
| CN1111414C (en) * | 1994-05-25 | 2003-06-18 | G·凡莱塔 | Pharmaceutical use of magnesium salts or magnesium complexes |
| US6589564B2 (en) | 1994-05-25 | 2003-07-08 | Giampiero Valletta | Use of magnesium based products for the treatment of neoplastic diseases |
| JP2003534373A (en) * | 2000-06-02 | 2003-11-18 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Composition for treating and / or preventing osteoporosis and / or inflammatory joint disease |
| DE112006003954T5 (en) | 2006-07-18 | 2009-05-07 | Mitsubishi Electric Corp. | Device with a numerical control |
| JP2014501722A (en) * | 2010-11-18 | 2014-01-23 | アドビセンヌ | Pharmaceutical compositions comprising Krebs cycle precursor salts, in particular citrate, and their use as medicaments |
| JP2017061553A (en) * | 2010-11-18 | 2017-03-30 | アドビセンヌ | Pharmaceutical compositions comprising Krebs cycle precursor salts, in particular citrate, and their use as medicaments |
| EP4389120A1 (en) * | 2022-12-20 | 2024-06-26 | Inflacod Sp. z o.o. | An anti-inflammatory pharmaceutical composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN91067A1 (en) | PROCESS FOR THE PREPARATION OF SUSTAINED RELEASE COMPOSITIONS AND COMPOSITIONS THUS OBTAINED. | |
| EP0311954A3 (en) | Use of sulfamic acid to inhibit phosphonate decomposition by chlorine-bromine mixtures | |
| CA2022392A1 (en) | 4-phosphonomethyl-2-hydroxy-2-oxo-1,4,2-oxazaphosphorinane n-oxide and water-soluble salts thereof | |
| NO931832D0 (en) | PROCEDURE AND MIXING FOR CONTROLLED RELEASE OF BIOLOGICAL ACTIVE AGENTS | |
| JPS6416A (en) | Remedy for arthritis | |
| BR8700955A (en) | MICROBICIDES PROCESS AND COMPOSITIONS TO COMBAT OR INHIBIT A CULTURE PLANT INFESTATION BY PHYTOPATHOGENIC MICROORGANISMS | |
| EP0664128A4 (en) | PHARMACEUTICAL COMPOSITION USED TO INHIBIT THE PRODUCTION OF TUMOR NECROSIS FACTORS. | |
| IT7924582A0 (en) | ALGICIDAL COMPOSITION AND METHOD TO PREVENT OR FIGHT THE FORMATION OF ALGAE WITH SAID COMPOSITION, AS WELL AS DIAMINES AND THEIR PREPARATION. | |
| KR850004393A (en) | Sustained Release Acetylsalicylic Acid Formulation for Oral Administration | |
| JPS55152597A (en) | Treatment of waste water containing organophoshoric compound | |
| JPS51116197A (en) | Method for production of removing agent for phosphate in solution | |
| Hudson et al. | Eutrophication: with particular reference to the role of phosphates. | |
| JPS5651991A (en) | Preparation of l-dihydroxyphenylalanine | |
| BR0115161A (en) | Passivation Method | |
| DE261607T1 (en) | BIOCIDES FOR THE TREATMENT OF COMMERCIAL WASTEWATER, IN PARTICULAR GAS WASHER SLUDGE. | |
| RU98111171A (en) | COMPOSITION FOR TREATMENT OF BOTTOM-HOLE ZONE | |
| JPS646214A (en) | Remedy for ulcerative colonopathy | |
| Glarborg Jörgensen et al. | Salicylate effects on gastric acid secretion | |
| EP0183144A3 (en) | Polycarbonates with dimethylmaleinimide end groups, optionally mixed with known aromatic polycarbonates, their preparation and their modification | |
| SU549151A1 (en) | Bath aid | |
| JPS5224188A (en) | Treatment of aluminum-sludge including phosphorus | |
| Williams | A Bronze Matrix for a Cuirass Pteryx | |
| DE895121C (en) | Process for the treatment of carbonated water | |
| Hauffe | Process for Producing Phosphate Coatings and Their Use | |
| RU98103699A (en) | METHOD FOR TREATING ALLERGIC DERMATITIS |